Sierra Medical

Sierra Medical is a pioneering software company that transforms spectral analytics for early disease detection. Their flagship product, AIR-DS, enables non-invasive cancer detection through a simple cheek swab, achieving high accuracy rates. The company aims to streamline laboratory processes, making advanced analytics accessible to various industries, including healthcare and biotech. With a focus on quality and innovation, Sierra Medical is positioned to revolutionize early disease detection and improve patient outcomes.

AnalyticsArtificial IntelligenceBiotechnologyCancer DetectionHealthcareMedical DeviceNon-invasiveSpectroscopysierramedical.co.uk

Sierra Medical

AnalyticsArtificial IntelligenceBiotechnologyCancer DetectionHealthcareMedical DeviceNon-invasiveSpectroscopysierramedical.co.uk

HQAbingdon, GB

Team Size9

Open Jobs2

Total Funding-

Latest Fundraise4 years ago

Join the Team

Institutional Strategic Partner

RemoteUS

Remote • US

Teeming tracks opportunities at over 24,000 AI startups, then works with you to find (and land) the one you'll love.

AI Researcher

Full-timeHamburg, DE

Full-time • Hamburg, DE

Mobile Developer

Full-timeLondon, GB

Full-time • London, GB

Machine Learning Engineer

Part-timeNew York, US

Part-time • New York, US

Frontend Developer

Full-timeHamburg, DE

Full-time • Hamburg, DE

Product Designer

ContractHaifa

Contract • Haifa

Technical Writer

ContractBerlin, DE

Contract • Berlin, DE

ABOUT SIERRA MEDICAL

Sierra Medical is advancing a new era of diagnostic medicine through infrared spectral analysis and explainable machine learning. Our flagship system, AIR-DS Lung, detects early-stage lung cancer from a cheek swab using standard laboratory equipment offering over 90% diagnostic accuracy with no hardware changes, no reagents, and no workflow disruption.

Sierra has now entered a pivotal enterprise growth phase:

IRB approval at a leading U.S. cancer centre
13 active clinical trial sites, expanding to nationwide coverage
Clinical deployment of AIR-DS Version 1.0.0, enabling real-world use in regulated environments
Rapid expansion across lung cancer networks, advocacy groups, and U.S. research institutions
Early engagement with top-tier U.S. and UK funds preparing for Sierra’s next capital cycle
Strengthening of U.S. operations, regulatory infrastructure, and clinical leadership
Growing interest from CLIA/ISO lab networks seeking scalable early-detection workflows

Sierra is now building a select group of institutional partners to support multi-site integration, scaling, and enterprise adoption.

THE ROLE

We are seeking Institutional Strategic Partners

: leaders across diagnostics, oncology, imaging, population health, digital pathology, enterprise healthcare, and AI-driven clinical technology to collaborate at a strategic level as Sierra prepares for large-scale deployment.

Strategic Partners may contribute to:

National and international scaling across CLIA and ISO laboratory networks
Multi-centre clinical validation strategy and regulatory expansion
Enterprise health-system integration, workflow mapping, and adoption frameworks
Strategic pathway development for spectral diagnostics across multiple diseases
Commercial strategy across oncology, precision medicine, and AI-enabled workflows
Key partnerships with cancer centres, biobanks, R&D groups, enterprise healthcare systems, and corporate innovation teams

Compensation:

Equity-based strategic collaboration

Commitment:

High-level strategic sessions; not operational

WHY THIS ROLE MATTERS

Sierra is transitioning from validated science into scalable clinical utility.

Institutional partners will help shape:

U.S. commercialization and lab-network deployment
Strategic direction for the AIR-DS platform and data ecosystem
Partnerships with enterprise health systems and global diagnostic firms
Expansion into new indications supported by spectral signatures and AI modeling
Sierra’s development into a multi-indication, multi-market diagnostics platform

This is a unique opportunity to support a clinically validated, globally scalable diagnostic technology at a defining inflection point.

IDEAL PARTNER PROFILES

Corporate venture or strategic partnership teams in diagnostics, oncology, imaging, or digital pathology
Executives from enterprise health systems, academic medical centres, or national lab networks
Leaders with experience commercializing regulated diagnostics, LDTs, or AI-driven clinical systems
Investors or strategists in precision medicine, spectral/biochemical analysis, or early detection
Experts in multi-site clinical validation, large-scale trial oversight, or CLIA/ISO implementation
Healthcare investors interested in participating in strategic growth discussions

EQUAL OPPORTUNITY COMMITMENT

Sierra Medical is committed to building a diverse, inclusive, and clinically representative advisory community. We welcome applicants from all backgrounds and do not discriminate on the basis of race, gender, ethnicity, disability, age, religion, or any protected characteristic. We believe that diverse clinical and leadership perspectives strengthen our mission to make early, accessible disease detection a global reality.